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The HEXIM1 protein inhibits the kinase activity of P-TEFb (CDK9/cyclin T) to suppress RNA polymerase
II transcriptional elongation in a process that specifically requires the 7SK snRNA, which mediates the
interaction of HEXIM1 with P-TEFb. In an attempt to define the sequence requirements for HEXIM1 to
interact with 7SK and inactivate P-TEFb, we have identified the first 18 amino acids within the previously
described nuclear localization signal (NLS) of HEXIM1 as both necessary and sufficient for binding to 7SK in
vivo and in vitro. This 7SK-binding motif was essential for HEXIM1’s inhibitory action, as the HEXIM1
mutants with this motif replaced with a foreign NLS failed to interact with 7SK and P-TEFb and hence were
unable to inactivate P-TEFb. The 7SK-binding motif alone, however, was not sufficient to inhibit P-TEFb. A
region C-terminal to this motif was also required for HEXIM1 to associate with P-TEFb and suppress
P-TEFb’s kinase and transcriptional activities. The 7SK-binding motif in HEXIM1 contains clusters of
positively charged residues reminiscent of the arginine-rich RNA-binding motif found in a wide variety of
proteins. Part of it is highly homologous to the TAR RNA-binding motif in the human immunodeficiency virus
type 1 (HIV-1) Tat protein, which was able to restore the 7SK-binding ability of a HEXIM1 NLS substitution
mutant. We propose that a similar RNA-protein recognition mechanism may exist to regulate the formation of
both the Tat–TAR–P-TEFb and the HEXIM1–7SK–P-TEFb ternary complexes, which may help convert the
inactive HEXIM1/7SK-bound P-TEFb into an active one for Tat-activated and TAR-dependent HIV-1
transcription.
During transcription by RNA polymerase II (Pol II), phos-
phorylation of the carboxy-terminal domain (CTD) of the larg-
est subunit of Pol II by the positive transcriptional elongation
factor b (P-TEFb) is crucial for the transition from the abortive
to the productive phase of transcriptional elongation, leading
to the generation of full-length RNA transcripts (for reviews,
see references 7 and 14). Active P-TEFb is composed of CDK9
and its regulatory subunit, cyclin T1 (CycT1) (14). Unlike other
CDKs and their cyclin partners whose functions are closely
related to the cell cycle regulation, P-TEFb is constitutively
expressed and, hence, its protein level varies little throughout
the cell cycle (5). Not only is P-TEFb essential for the expres-
sion of most protein-encoding genes (2, 16), but also it is
indispensable for the replication of human immunodeficiency
virus type 1 (HIV-1), since it is a specific host cellular cofactor
for the viral Tat protein (7, 14). P-TEFb is recruited by Tat to
the HIV-1 long terminal repeat (LTR) through the formation
of a stable ternary complex consisting of P-TEFb, Tat, and the
TAR RNA stem-loop structure located at the 5 end of the
nascent viral transcript (14). Once recruited, P-TEFb phos-
phorylates the Pol II CTD and stimulates the production of
full-length HIV-1 transcripts.
Not every P-TEFb complex in the cell can function as a
transcription factor. P-TEFb has been shown to lose its ability
to phosphorylate the CTD and stimulate transcriptional elon-
gation when associated with 7SK RNA (11, 20), a 330-nucle-
otide small nuclear RNA (snRNA) conserved in higher eu-
karyotes (10, 18, 24). Our recent in vitro reconstitution studies
indicated that the association with 7SK is necessary but not
sufficient to inactivate P-TEFb (21). Rather, a protein factor
called HEXIM1, which has been identified as the third protein
component of the 7SK–P-TEFb snRNP formed in vivo (9, 21),
potently and specifically inhibits the kinase and transcriptional
activities of P-TEFb in a 7SK-dependent manner (21).
HEXIM1 has previously been identified as a nuclear protein
whose expression is rapidly induced in cells treated with hexa-
methylene bis-acetamide (12), a potent inducer of cell differ-
entiation (8). The 7SK-dependent inhibition of P-TEFb by
HEXIM1 can be explained by the observation that 7SK plays a
scaffolding role in mediating the interaction between HEXIM1
and P-TEFb, enabling HEXIM1 to exert its inhibitory effect on
P-TEFb (9, 21).
Roughly half of nuclear P-TEFb in HeLa cells is sequestered
in an inactive state within the 7SK snRNP. However, this
population of P-TEFb can be rapidly dissociated from 7SK and
HEXIM1 upon treatment of cells with certain stress-inducing
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agents (9, 11, 20, 21), some of which have been shown to
stimulate the CTD phosphorylation and HIV-1 transcription at
low dosages (1, 17). In addition, hypertrophic signals have been
shown to activate P-TEFb in cardiac myocytes by disrupting
the 7SK snRNP, leading to an accumulation of active, 7SK/
HEXIM1-free P-TEFb in the cell. This in turn causes the
stimulation of CTD phosphorylation as well as a global in-
crease in RNA and protein contents, which eventually promote
cardiac hypertrophy (15). Hence, the abilities of these stress-
or hypertrophy-inducing agents to release 7SK/HEXIM1 and
activate P-TEFb provide a mechanistic explanation for their
effects on transcriptional activation.
Although the signaling pathway(s) leading to the stress- or
hypertrophy-induced disruption of the 7SK snRNP is currently
unknown, reversible phosphorylation of CDK9 is likely to play
an important role in governing the formation and disruption of
the snRNP. We have recently shown that phosphorylation of
CDK9, on possibly the conserved Thr186 in the T-loop, is
important for the 7SK–P-TEFb interaction (3). Mutation of
only Thr186, but not the other known phosphorylated residues
in CDK9, abolishes the 7SK–P-TEFb interaction both in vivo
and in vitro.
It is important to further characterize the various interac-
tions within the 7SK–HEXIM1–P-TEFb snRNP, which ulti-
mately control the nuclear level of active P-TEFb for general
and disease-related transcription. In this study, we focused on
the newly discovered HEXIM1 protein and investigated the
sequence requirements for HEXIM1 to bind 7SK and P-TEFb
and to inactivate P-TEFb. We have identified an 18-amino-
acid (aa) arginine-rich 7SK-binding motif within the nuclear
localization signal (NLS) of HEXIM1 that was essential for
HEXIM1’s inhibitory effect on transcription through a 7SK-
mediated interaction with P-TEFb. However, the 7SK-binding
motif alone was incapable of inactivating P-TEFb, and the
region of HEXIM1 C-terminal to this motif was essential for
this function. Interestingly, the arginine-rich 7SK-binding mo-
tif in HEXIM1 is highly homologous to the TAR RNA-binding
domain of the HIV-1 Tat protein. We speculate that this con-
served arginine-rich RNA-binding motif has evolved to facili-
tate the specific interactions of P-TEFb with HEXIM1 and Tat
via the 7SK and TAR RNA, respectively.
MATERIALS AND METHODS
cDNA constructs. Wild-type HEXIM1, N, and HEXIM1-NLS cloned into
pFlag-CMV2 were a generous gift from H. Tanaka from the University of Tokyo,
Tokyo, Japan. The pFlag-CMV2 plasmids containing the cDNAs for HXM1-
NLSSV40, HXM1-NLSTat, N-NLSSV40, HXM1(150-158A), HXM1(159-167A),
and HXM1(168-177A) were generated by a standard PCR protocol using cus-
tom-designed primers. For the generation of NLSHXM1-green fluorescent pro-
tein (GFP) and NLSSV40-GFP constructs, the sequences encoding the Flag-
tagged NLS of HEXIM1 or simian virus 40 (SV40) T antigen were joined to the
5 end of GFP by PCR and cloned into pcDNA3 (Invitrogen) using the HindIII
and XhoI sites.
Affinity purification of HEXIM1 and its associated factors for Northern and
Western analyses. Flag-tagged wild-type and mutant HEXIM1 proteins as well
as the NLS-GFP fusion proteins were expressed from cDNA constructs in HeLa
cells transfected with the Lipofectamine Plus reagent (Invitrogen). Nuclear ex-
tract (NE) was prepared from the transfected cells 48 h later. The HEXIM1
complexes were affinity purified from NE by incubating at 4°C for 2 h with
anti-Flag agarose beads (Sigma), followed by extensive washes with buffer D (20
mM HEPES-KOH [pH 7.9], 15% glycerol, 0.2 mM EDTA, 0.2% NP-40, 1 mM
dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride) containing 0.3 M KCl
(D0.3 M) and elution with the Flag peptide dissolved in D0.1 M. The eluted
materials were analyzed by Western blotting with anti-Flag (M2; Sigma), anti-
CDK9, and anti-CycT1 antibodies (Santa Cruz Biotechnology) and Northern
hybridization using the 32P-labeled full-length 7SK antisense RNA as the probe.
In vitro transcription assay. Flag-tagged wild-type and mutant HEXIM1 pro-
teins used in the transcription reactions were affinity purified by anti-Flag im-
munoprecipitation from NE of transiently transfected 293T cells. After extensive
washing with the high-salt buffer D containing 1.0 M KCl (D1.0 M) and then
D0.05 M, the immobilized Flag-HEXIM1 proteins were eluted with 0.5 mg of
Flag peptide/ml dissolved in D0.05 M. Prior to the transcription reactions, HeLa
NE in D0.1 M was preincubated at 30°C for 20 min with the affinity-purified
wild-type or mutant Flag-HEXIM1 proteins, in the presence of 0.5 mM ATP and
5 mM MgCl2. This step caused the phosphorylation of the endogenous 7SK/
HEXIM1-free P-TEFb, enabling its subsequent binding to the exogenously
added HEXIM1 to form the HEXIM1–7SK–P-TEFb complex (3). The in vitro
transcription reactions containing two HIV-1 DNA templates, pHIVTAR-
G400 and pHIVTAR-G100, were performed essentially as described previously
(22).
Immunofluorescence staining. Cells transfected with various HEXIM1 cDNA
constructs were grown in Lab-Tek II chamber slides (Nalge Nunc International)
to 70% confluence and fixed with 4% formaldehyde in phosphate-buffered
saline (PBS) at room temperature for 20 min. The rest of the procedure was
performed on ice. Cells were permeabilized with ice-cold 0.1% Triton X-100 in
PBS for 5 min and then washed in PBS, followed by incubation with 10% goat
serum in PBS for 15 min to block nonspecific binding sites. Mouse anti-Flag
antibody was added to a final concentration of 1 g/ml. After incubation for 1 h,
cells were washed extensively in PBS and then incubated for 30 min with goat
anti-mouse immunoglobulin G conjugated to Alexa Fluor 488 at a 1:2,000 dilu-
tion (Molecular Probes).
Gel mobility shift assay. Flag-tagged NLSHXM1-GFP and NLSSV40-GFP pro-
teins were immunoprecipitated from NE of transfected HeLa cells. Proteins
immobilized on anti-Flag beads were incubated with RNase A and washed
stringently with the high-salt buffer D1.0 M to strip away any associated RNA
and proteins. The Flag peptide-eluted proteins were then incubated with the
32P-labeled in vitro-transcribed sense- or antisense 7SK RNA in D0.05 M plus 1
mg of bovine serum albumin/ml, and 0.7 mg of yeast tRNA/ml. To supershift the
complex, the anti-Flag monoclonal antibody was added at 2.4 g/reaction mix-
ture. The RNA-protein complexes were resolved in a 4% nondenaturing poly-
acrylamide gel in 0.5 Tris-glycine electrophoresis buffer at room temperature.
Luciferase assay. HeLa cells grown in six-well cluster dishes were cotrans-
fected with 100 ng of a luciferase reporter construct driven by the HIV-1 LTR
(21) and with increasing concentrations of plasmids expressing either wild-type
HEXIM1, NLS-replaced or -deleted HEXIM1 mutants, or NLS-GFP fusion
proteins. The total amount of plasmids was kept constant for each transfection
by adjusting with the empty vector. Luciferase activity was measured 48 h later.
In vitro kinase assay. In vitro kinase reactions to detect the phosphorylation
of GST-CTD by P-TEFb and to analyze the effect of wild-type and mutant
HEXIM1 proteins on P-TEFb’s kinase activity were performed as described
previously (21).
RESULTS
Targeting HEXIM1 to the nucleus through a heterologous
NLS domain. The full-length HEXIM1 protein, consisting of
359 aa (Fig. 1A), can be divided into three regions: an N-
terminal proline-rich region (aa 1 to 149), a central region (aa
150 to 177) containing an unusually long bipartite NLS (12),
and a C-terminal acidic region (aa 178 to 359) enriched in Asp
and Glu residues. We have previously shown that two
HEXIM1 truncation mutants, lacking either the N- or C-ter-
minal region but still retaining the central NLS domain, have
similar affinities for 7SK when compared to the wild-type
HEXIM1 (21). Since the only region common to these two
truncated mutants is the NLS, this domain could potentially
contain both an NLS as well as a 7SK-binding motif.
To test whether the 28-aa NLS of HEXIM1 contains a 7SK-
binding motif, it was replaced by the 10-aa prototype NLS
(PKKKRKVEDP) derived from the SV40 large T antigen (6),
resulting in the generation of HXM1-NLSSV40 (Fig. 1A). Next,
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the subcellular localization of the Flag-tagged wild-type
HEXIM1 (fHXM1) and fHXM1-NLSSV40 in transiently trans-
fected HeLa cells was examined by anti-Flag immunofluores-
cence staining. Both proteins were similarly located in the
nucleus (Fig. 1B), indicating that the SV40 NLS was able to
functionally replace the native HEXIM1 NLS as a nuclear
targeting signal. Like the transfected fHXM1, the endogenous
HEXIM1 was also stained as a nuclear protein (data not
shown). As a control, a HEXIM1 mutant lacking the central
NLS region (Fig. 1A, fHXM1-NLS) was excluded from the
nucleus (Fig. 1B), as previously reported (12).
We have previously shown that the N-terminally truncated
HEXIM1 mutant N (aa 150 to 359) efficiently interacted with
7SK and P-TEFb, causing the inhibition of P-TEFb’s kinase
and transcriptional activities (21). This finding implicates the
C-terminal region of HEXIM1 as the business end of the
molecule required for targeting and inactivating P-TEFb. Like
fHXM1 and fHXM1-NLSSV40, both fN and fN-NLSSV40, in
which the 28-aa NLS of HEXIM1 has been replaced with the
SV40 NLS (Fig. 1A), were found to localize to the nucleus of
the transfected HeLa cells (Fig. 1B).
The NLS domain of HEXIM1 is necessary for HEXIM1 to
bind to 7SK and P-TEFb. Given that both fHXM1-NLSSV40
and fN-NLSSV40 were properly targeted to the nucleus, we
asked whether these two proteins could interact with 7SK and
P-TEFb like their wild-type counterparts. Flag-tagged wild-
type and mutant HEXIM1 proteins and their associated fac-
tors were affinity purified from the NE of transfected HeLa
cells and analyzed by Western and Northern blotting. As ex-
pected, all the known components of the 7SK snRNP (7SK,
FIG. 1. HEXIM1 can be targeted to the nucleus through a heterologous NLS domain. (A) Domain structure of the Flag-tagged wild-type
HEXIM1 (fHXM1) containing the NTD and CTD and a central NLS. Also shown are fN, a truncated HEXIM1 missing the NTD; fHXM1-
NLS, a HEXIM1 mutant missing the central NLS; fHXM1-NLSSV40, a mutant with the native NLS replaced with the NLS of the SV40 T antigen;
and finally fN-NLSSV40, containing the SV40 NLS in place of the native NLS in fN. (B) The wild-type and mutant HEXIM1 proteins described
in panel A were expressed from transfected plasmids in HeLa cells, and their subcellular localizations were examined by anti-Flag immunofluo-
rescence staining.
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CDK9, and CycT1) were associated with both fHXM1 and fN
(Fig. 2A, lanes 2 and 6). Consistent with a previously demon-
strated structural role of 7SK in bridging the HEXIM1–P-
TEFb interaction (21), degradation of 7SK by RNase A during
immunoprecipitation disrupted the associations with P-TEFb
by both fHXM1 and fN (lanes 3 and 7). In contrast to these
two proteins containing the native HEXIM1 NLS domain,
fHXM1-NLSSV40 and fN-NLSSV40 interacted with very little
7SK and P-TEFb, either in the presence or absence of RNase
A (Fig. 2A, lanes 4, 5, 8, and 9). These results suggest that
although the NLS of the SV40 large T antigen was able to
direct the nuclear localization of the backbone HEXIM1 pro-
tein, the SV40 NLS-substituted HEXIM1 mutants apparently
lost the ability to form the 7SK snRNP. Thus, the native NLS
of HEXIM1 does not act merely as a nuclear targeting signal
but may also be required for 7SK binding, which in turn me-
diates the interaction between HEXIM1 and P-TEFb.
The NLS-substituted HEXIM1 mutants fail to inhibit P-
TEFb’s kinase activity. Next, in vitro kinase reactions with
P-TEFb as the kinase, GST-CTD as the substrate, and protein-
free total nuclear RNA as the source of 7SK were performed
to examine the abilities of wild-type and mutant HEXIM1 to
inhibit P-TEFb (21). Affinity purified from NE of transfected
293T cells, the immobilized fHXM1 proteins were stripped off
their associated factors by washing with the high-salt buffer
D1.0 M (containing 1.0 M KCl) (21) prior to elution with the
Flag peptide. The purity was confirmed by silver staining anal-
ysis (Fig. 2B, lanes 12 and 13, and data not shown). In kinase
reactions, wild-type fHXM1 and fN inhibited P-TEFb’s phos-
phorylation of GST-CTD in a process that specifically required
the presence of intact 7SK in the reactions (Fig. 2B, lanes 2 and
6, and C, lanes 2 and 5). No inhibition was detected when 7SK
in the total RNA fraction was first destroyed by the 7SK-
antisense deoxyoligonucleotide-mediated RNase H cleavage
(21). As for fHXM1-NLSSV40 and fN-NLSSV40, consistent
with their failure to bind to 7SK and P-TEFb, neither was able
to inhibit P-TEFb whether or not 7SK was present in the
reaction mixture (Fig. 2B, lanes 4 and 8, and C, lanes 3 and 6).
Because fHXM1-NLS was mostly cytoplasmic (Fig. 1B) and
unable to bind to 7SK/P-TEFb (data not shown), it also failed
to inhibit the P-TEFb kinase activity (Fig. 2B, lanes 3 and 7).
The NLS domain is required for HEXIM1 to inhibit re-
porter gene expression in vivo. We have previously shown that
when transiently expressed in HeLa cells, both wild-type and
N HEXIM1 efficiently inhibited the expression of the co-
transfected luciferase reporter gene driven by a variety of Pol
II promoters (21). To test whether the central NLS domain of
HEXIM1 is required for this inhibition, we compared fHXM1
with fHXM1-NLSSV40 and fN with fN-NLSSV40 for their
abilities to suppress the expression of the luciferase gene
driven by the HIV-1 LTR. Consistent with their abilities to
inhibit the P-TEFb kinase in vitro, luciferase gene expression
was significantly inhibited by both fHXM1 and fN (Fig. 3A
and B). In contrast, no or only very weak inhibition was ob-
served with fHXM1-NLSSV40 or fN-NLSSV40. As expected,
fHXM1-NLS, which lacks the central NLS domain, failed to
inhibit the luciferase gene expression.
NLS-substituted HEXIM1 mutants fail to inhibit transcrip-
tion in vitro. Having demonstrated that the transfected
fHXM1 and fN could suppress the reporter gene expression
in vivo, we next performed in vitro transcriptional studies to
seek a direct confirmation of the ability of these two proteins to
inhibit transcription and the requirement for their NLS do-
main in this process (Fig. 3C and D). Flag-tagged HEXIM1
proteins were affinity purified from NE of transfected cells,
stripped off their associated factors with high salt (Fig. 2B and
data not shown), and then added into transcription reaction
mixtures containing standard HeLa NE and two HIV-1 DNA
templates, pHIVTAR-G400 and pHIVTAR-G100 (23).
Again, both fHXM1 and fN, but not fHXM1-NLSSV40 or
fN-NLSSV40, were able to directly inhibit HIV-1 promoter-
distal transcription (i.e., transcriptional elongation) of two G-
less cassettes (G400 and G100) that were inserted, respectively,
into the two templates at 1 kb downstream of the start site
(Fig. 3C and D).
The isolated NLS domain of HEXIM1 binds strongly to 7SK
but poorly to P-TEFb in vivo. The data presented so far are
consistent with the idea that the central positively charged
domain in HEXIM1 functions as not only as an NLS but also
as a 7SK-binding domain required for HEXIM1 to target and
inactivate P-TEFb through the mediation of 7SK. However, a
trivial explanation also exists, which suggests that the replace-
ment of the native HEXIM1 NLS with a foreign sequence may
cause a conformational change in the overall protein structure,
leading to a loss of HEXIM1’s 7SK-binding ability. To rule out
this latter possibility, it was important to demonstrate directly
that the 28-aa HEXIM1 NLS domain indeed harbors a 7SK-
binding motif.
To this goal, we fused the Flag-tagged NLS domains of
HEXIM1 and SV40 T antigen to the N terminus of GFP,
resulting in the generation of two fusion proteins, fNLSHXM1-
GFP and fNLSSV40-GFP, respectively. When tested for their
abilities to bind to 7SK/P-TEFb in transiently transfected
HeLa NE, 7SK was found to coimmunoprecipitate with
fNLSHXM1-GFP (Fig. 4A, lane 3) but not fNLSSV40-GFP (lane
4). Compared to wild-type fHXM1, fNLSHXM1-GFP bound to
slightly more 7SK (lanes 2 and 3), suggesting that a fully func-
tional 7SK-binding motif is present within the 28-aa NLS do-
main of HEXIM1. However, unlike fHXM1, NLSHXM1-GFP
coimmunoprecipitated only trace amounts of CycT1 and
CDK9 (Fig. 4A), indicating that the HEXIM1 NLS alone was
not sufficient to recruit the same amount of P-TEFb that was
found in the full-length HEXIM1/7SK complex. Because the
HEXIM1 N mutant is fully able to bind to P-TEFb (21) (Fig.
2A), a region from aa 178 to 359, which is outside of the NLS
but within the C-terminal half of HEXIM1, is likely to con-
tribute to the recruitment of P-TEFb through additional pro-
tein-protein interactions with P-TEFb.
The isolated HEXIM1 NLS binds 7SK with slightly reduced
specificity. Given that the 28-aa HEXIM1 NLS alone was fully
capable of interacting with 7SK, we examined the specificity of
this interaction by analyzing whether other abundant snRNA
species (e.g., U1 and U2 snRNAs) besides 7SK could also
coimmunoprecipitate with fNLSHXM1-GFP in transfected
HeLa NE. Northern analyses in Fig. 4B revealed that the
immunoprecipitates from cells transfected with either an
empty vector (lane 2) or a construct producing fNLSSV40-GFP
(lane 5) did not contain any 7SK, U1, or U2. Wild-type
fHXM1, on the other hand, interacted with only 7SK but not
U1 and U2, as expected (lane 3). Interestingly, although
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FIG. 2. The native NLS domain is required for HEXIM1 to bind to 7SK and P-TEFb and inhibit P-TEFb’s kinase activity. (A) The
NLS-substituted HEXIM1 mutants fail to bind to 7SK and P-TEFb in vivo. Anti-Flag immunoprecipitation (IP) was performed in NE of HeLa
cells transfected with either an empty vector (lane 1) or constructs expressing the indicated Flag-tagged HEXIM1 proteins (lanes 2 to 9). The
peptide-eluted immune complexes were analyzed by Western blotting (WB) for the presence of CDK9, CycT1, and HEXIM1 and by Northern
blotting (NB) for 7SK. (B) The native NLS is required for HEXIM1 to inhibit the P-TEFb kinase in a 7SK-dependent manner. Kinase reaction
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fNLSHXM1-GFP associated with a similar amount of 7SK as
did fHXM1, it also coprecipitated small amounts of U1 and U2
in NE (lane 4), indicating that the specificity of the isolated
HEXIM1 NLS for 7SK was somewhat reduced compared to
that of the full-length protein. Quantification of the amount of
snRNAs coimmunoprecipitated with fNLSHXM1-GFP indi-
cated that, compared to the three RNA species present in NE
(lane 1), 7SK was 8 times more likely than U1 and U2 to bind
to fNLSHXM1-GFP. Thus, although the isolated HEXIM1 NLS
showed a slightly reduced specificity for 7SK, it was still much
higher than for the other snRNA species tested.
The isolated HEXIM1 NLS binds 7SK directly in the ab-
sence of other factors. To rule out the possible involvement of
another unknown factor(s) in mediating the in vivo interaction
between fNLSHXM1-GFP and 7SK, a gel mobility shift assay
was performed to determine whether there was a direct inter-
action between these two molecules in vitro. fNLSHXM1-GFP
and fNLSSV40-GFP proteins were immunoprecipitated from
the transfected HeLa NE, treated with RNase A and high salt
(0.8 M KCl) to remove any associated factors (3), and eluted
off the beads with the Flag peptide. The two proteins, affinity
purified to single polypeptides as determined by silver staining
analysis (data not shown), were subsequently incubated with
32P-labeled, in vitro-transcribed sense or antisense 7SK RNA.
The RNA-protein complexes were then resolved in a nonde-
naturing polyacrylamide gel. As shown in Fig. 4C, incubation
with fNLSHXM1-GFP but not fNLSSV40-GFP caused a shift in
the mobility of only the sense 7SK RNA. The fNLSHXM1-
GFP–7SK complex could be supershifted with the anti-Flag
monoclonal antibody, which reacted with Flag-tagged
fNLSHXM1-GFP. In agreement with the above-described high
specificity of the isolated HEXIM1 NLS for 7SK, fNLSHXM1-
GFP did not bind to the antisense 7SK RNA (Fig. 4C). Taken
together, these results confirmed that the NLS of HEXIM1
indeed contains a bona fide 7SK-binding motif.
The HEXIM1 NLS alone is unable to inhibit P-TEFb kinase
and Pol II transcription. Although it was fully active in binding
7SK, the isolated HEXIM1 NLS interacted poorly with P-
TEFb when fused to GFP (Fig. 4A). Reflecting this inability to
target P-TEFb, fNLSHXM1-GFP failed to inhibit P-TEFb’s ki-
nase activity whether or not 7SK was present in the reaction
mixture (Fig. 5A). Furthermore, unlike wild-type fHXM1, nei-
ther fNLSHXM1-GFP nor fNLSSV40-GFP produced from a
transfected plasmid was able to inhibit the expression of a
cotransfected luciferase reporter gene driven by the HIV-1
LTR (Fig. 5B). Thus, although the isolated HEXIM1 NLS
bound to 7SK, this binding alone did not inactivate P-TEFb.
Because the N-terminally deleted fN was fully active in bind-
ing to and suppressing P-TEFb (Fig. 2 and 3), a region outside
of the NLS but within the C-terminal half of HEXIM1 likely
cooperated with the 7SK-binding motif and was required for
HEXIM1 to target and inhibit P-TEFb.
The first 18 residues of the HEXIM1 NLS are important for
7SK binding. To further define the residues within the
HEXIM1 NLS that are important for 7SK binding, we divided
this 28-aa domain into three sections of roughly equal sizes and
mutated all residues within each section to Ala (Fig. 6A). The
alanine-substitution mutants generated in either the full-length
HEXIM1 (Fig. 6A) or the NLS-GFP (data not shown) back-
ground were all localized to the nucleus as revealed by fluo-
rescence microscopy, indicating that there was functional re-
dundancy for nuclear targeting among the residues within the
HEXIM1 NLS. The abilities of these alanine-substitution mu-
tants to interact with 7SK were then assessed by anti-Flag
immunoprecipitation from NE of transfected HeLa cells. Sub-
stitution of aa 150 to 158 and aa 159 to 167 in either the
HEXIM1 (Fig. 6B, lanes 3 and 4) or the NLS-GFP (lanes 7 and
8) background significantly weakened or completely abolished
7SK binding. In contrast, mutation of aa 168 to 177 into Ala in
HEXIM1 only moderately reduced its binding to 7SK (Fig. 6B,
lane 5), and the same mutation introduced into the NLS-GFP
background had no detectable effect on 7SK binding (lane 9).
Thus, while aa 150 to 167 within the HEXIM1 NLS were
mostly indispensable for 7SK binding, aa 168 to 177 had a
relatively minor role in this process.
A duplicated arginine-rich TAR-binding motif of HIV-1 Tat
can substitute for the HEXIM1 7SK-binding motif. Consistent
with the observation that aa 150 to 167 of the HEXIM1 NLS
are important for 7SK binding, sequence alignment among the
human and mouse HEXIM1 and HEXIM2 (unpublished data)
as well as the zebrafish HEXIM proteins has revealed that the
highest amino acid identity or similarity within the 28-aa NLS
domain is indeed concentrated near the N-terminal two-thirds
of this region (Fig. 7A). These 18 residues displayed an intrigu-
ing pattern of two consecutive segments linked by a conserved
serine, with each segment consisting of six to seven basic res-
idues followed by a proline (KKKHRRRP and KKKRHWKP)
(Fig. 7A). Comprehensive BLAST analysis revealed that the
first segment (aa 150 to 157) was remarkably similar to the
arginine-rich TAR RNA-binding motif of the HIV-1 Tat pro-
tein, particularly that of the Finland strain (Fig. 7A). There is
only one conserved amino acid change (Lys versus Arg) in the
entire eight-residue segment shared by the two proteins. How-
ever, this Tat-like eight-residue segment was not sufficient to
mediate HEXIM1-7SK binding, as illustrated by the failure to
bind 7SK by both the full-length HEXIM1 and the NLS-GFP
fusion protein containing wild-type sequences in this segment
but Ala substitutions in the second segment of the 7SK-binding
motif of HEXIM1 (Fig. 6B, 150 to 158A mutants).
Since the second segment of HEXIM1’s bipartite 7SK-bind-
ing motif is also positively charged and shows partial resem-
blance to the TAR-binding motif of Tat, we decided to replace
this segment with the arginine-rich Tat sequences. The
fHXM1-NLSTat mutant thus created contained essentially a
mixtures contained the affinity-purified wild-type or mutant HEXIM1, P-TEFb, GST-CTD, and the indicated RNA fractions. Total RNA was
extracted from HeLa NE, which had been subjected to deoxyoligonucleotide-directed RNase H cleavage in the presence of 7SK antisense or
scrambled oligonucleotide. Lanes 1 to 8, phosphorylated GST-CTD as detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
autoradiography. Lanes 9 to 11, relative amounts of HEXIM1 proteins used in the kinase reactions as determined by anti-Flag Western blotting.
Lanes 12 and 13, purity of wild-type fHXM1 affinity purified from transfected cells as indicated by silver staining. (C) The HEXIM1 NLS is required
for fN to inhibit P-TEFb kinase. Kinase reactions containing the indicated HEXIM1 mutants were performed exactly as for panel B.
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FIG. 3. The native NLS domain is required for HEXIM to inhibit transcription in vivo and in vitro. (A and B) The HEXIM1 NLS is required
for both fHXM1 and fN to inhibit reporter gene transcription in vivo. HeLa cells were transfected with an HIV-1 LTR-luciferase reporter
construct together with either an empty vector (V) or the indicated HEXIM1-expressing plasmid (at a twofold increment). The total amount of
transfected DNA was kept constant by adjusting with the empty vector. Top panels: luciferase activities measured 48 h later; data from three
independent experiments are shown. Bottom panels: levels of the Flag-tagged HEXIM1 proteins in transfected cell lysate determined by anti-Flag
Western blotting. (C and D) The NLS-substituted HEXIM1 mutants fail to inhibit transcription in vitro. Flag-tagged wild-type and mutant
HEXIM1 proteins were affinity purified from NE of transfected HeLa cells, stripped off their associated factors, and added into transcription
reaction mixtures containing standard HeLa NE and two transcription templates, HIVTAR-G400 and HIVTAR-G100. RNA fragments
transcribed from two G-less cassettes inserted, respectively, into the two templates at a position 1 kb downstream of the HIV-1 promoter were
indicated. The amounts of HEXIM1 proteins used in the reaction mixtures were examined by Western blotting in lanes 6 and 7.
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FIG. 4. Direct and selective binding of the isolated NLS domain of HEXIM1 to 7SK in vivo and in vitro. (A) Efficient in vivo binding of the
isolated NLS of HEXIM1 to 7SK but not P-TEFb. Anti-Flag immunoprecipitation (IP) was performed in NE of HeLa cells transfected with either
an empty vector or vectors expressing the indicated Flag-tagged proteins. The peptide-eluted immune complexes were examined by Western
blotting (WB) with antibodies against CDK9, CycT1, and Flag and Northern blotting (NB) with antisense 7SK RNA as the probe. (B) The isolated
NLS of HEXIM1 binds 7SK with slightly reduced selectivity. Results shown are from Northern analyses of the levels of 7SK, U1, and U2 snRNAs
present in HeLa NE and the various immune complexes (Flag IP) obtained in panel A. (C) Direct binding of the isolated HEXIM1 NLS to 7SK
in the absence of other factors. The indicated GFP fusion proteins were affinity purified from transfected cells, stripped off their associated factors,
and analyzed in a gel mobility shift assay for their abilities to interact with the antisense (lanes 1 to 3) and sense (lanes 4 to 8) 7SK RNA. Anti-Flag
monoclonal antibody was also present in the reaction mixtures in lanes 7 and 8. The amounts of GFP fusion proteins used in the reactions were
examined by Western blotting in lanes 9 and 10.
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duplicated TAR-binding motif of Tat separated by a conserved
Ser (Fig. 7A). Remarkably, this substitution mostly restored
the ability of HEXIM1 to bind to 7SK and P-TEFb, as dem-
onstrated by the detection of 7SK, CDK9, and CycT1 associ-
ated with the immunoprecipitated fHXM1-NLSTat (Fig. 7B).
Like the situation involving wild-type fHXM1, degradation of
7SK by RNase A prior to immunoprecipitation also disrupted
the binding of fHXM1-NLSTat to P-TEFb (lanes 4 and 5),
again revealing an RNA-dependent interaction between the
two. However, compared to wild-type fHXM1, fHXM1-
NLSTat appeared to bind to 7SK with slightly decreased spec-
ificity, as suggested by its coprecipitation with small amounts of
U1 and U2 snRNAs in transfected cell NE (Fig. 7C). Quanti-
tative analysis of the amounts of 7SK, U1, and U2 in both the
immunoprecipitates and NE indicated that fHXM1-NLSTat
was at least 10 times more likely to interact with 7SK than with
U1 and U2, demonstrating its fairly selective if not entirely
exclusive binding to 7SK. Importantly, like fHXM1, the ability
of fHXM1-NLSTat to target P-TEFb through a 7SK-mediated
interaction resulted in an efficient inhibition of HIV-1 LTR-
driven luciferase gene expression in vivo (Fig. 7D). Together,
these data reinforce the idea that a bipartite HIV-1 Tat-like
arginine-rich RNA-binding domain is essential for HEXIM1 to
inhibit RNA Pol II transcription through a 7SK-mediated in-
teraction with and inactivation of P-TEFb.
DISCUSSION
HEXIM1 and its homologues constitute a unique class of
cyclin-dependent kinase inhibitors that require an RNA cofac-
tor, 7SK, to mediate their interactions with and inactivation of
the target kinase, P-TEFb. 7SK has been shown to interact
with P-TEFb containing the phosphorylated T-loop in CDK9,
and the different phosphorylation states control the formation
and disruption of the 7SK snRNP in response to various phys-
iological stimuli (3). In contrast, little is known about the
molecular determinants in HEXIM1 that are key for interact-
ing with 7SK and suppressing P-TEFb. Here, we demonstrate
that a previously described NLS located near the center of
HEXIM1 also functions as a 7SK-binding domain. While the
region N-terminal to this domain plays a regulatory role in
modulating the interaction between HEXIM1 and 7SK (21),
the C-terminal region is essential for HEXIM1 to bind to and
inhibit P-TEFb.
This important role of the HEXIM1 C-terminal region has
been implicated by several observations. First, this region has
been shown to interact directly with CycT1 in a Saccharomyces
cerevisiae two-hybrid assay (9). Consistent with this, the C-
terminal-deleted HEXIM1 binds significantly less P-TEFb in
vivo and thus has markedly reduced ability to inactivate P-
TEFb when compared to the full-length protein (21). Finally,
because of the lack of the C-terminal region that is key for
forming the complete 7SK snRNP, the isolated 7SK-binding
domain of HEXIM1 interacted efficiently with 7SK but poorly
with P-TEFb (Fig. 4A) and was therefore unable to inactivate
P-TEFb (Fig. 5). Together, these data support a model that the
7SK-binding domain and the C-terminal P-TEFb-targeting re-
gion are both required for HEXIM1 to inhibit P-TEFb in a
7SK-dependent fashion. When the HEXIM1 NLS was re-
placed with a foreign NLS, the mutant HEXIM1 was properly
directed to the nucleus but failed to bind to 7SK and therefore
could not interact with P-TEFb. This in turn resulted in the
inability of the mutant to inhibit P-TEFb’s kinase and tran-
scriptional activities (Fig. 2 and 3). These data reaffirm the
notions that the 7SK snRNA plays a scaffolding role in medi-
ating the HEXIM1–P-TEFb interaction and that P-TEFb is
the functional target of HEXIM1/7SK’s inhibitory action on
transcription.
We have pinpointed the first 18 aa (aa 150 to 167) within the
HEXIM1 NLS domain as residues constituting the 7SK-bind-
ing motif. When fused to GFP, they are sufficient for 7SK
binding. Of those 18 residues, there are 14 invariable and 4
FIG. 5. The HEXIM1 NLS alone fails to inhibit P-TEFb kinase
and Pol II transcription. (A) The isolated HEXIM1 NLS cannot inhibit
the P-TEFb kinase. Kinase reactions containing P-TEFb as the kinase,
GST-CTD as the substrate, and the total RNA fraction treated by
RNase H cleavage in the presence of 7SK-antisense or scrambled
oligonucleotide were performed as for Fig. 2B. Buffer alone, fHXM1,
or the indicated affinity-purified GFP fusion proteins were added into
the reaction mixtures to inhibit the P-TEFb kinase. (B) The isolated
NLS of HEXIM1 does not suppress the luciferase gene expression
driven by the HIV-1 LTR. HeLa cells were cotransfected with the
HIV-1 LTR-luciferase reporter construct and the indicated expression
plasmids as for Fig. 3A. Top panel: luciferase activity was measured
48 h later, and data from three independent experiments are shown.
Bottom panel: anti-Flag Western analysis of the levels of the trans-
fected Flag-tagged proteins in whole-cell lysate.
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highly conserved ones, as revealed by sequence alignment of
the human, mouse, and zebrafish HEXIM1 homologues or
paralogues (Fig. 7A). This coincides with the fact that the 7SK
snRNA sequences are also highly conserved throughout evo-
lution (e.g., human and mouse 7SK sequences are 99% iden-
tical). The high degree of conservation of both the amino acids
and nucleotides involved in the 7SK-HEXIM1 interaction in-
dicates an important and highly conserved function of this
interaction in controlling P-TEFb activity and RNA Pol II
transcription across diverse animal species.
The 7SK-binding motif in HEIXM1 displays an interesting
pattern of two consecutive segments connected by a conserved
serine, with each segment consisting of six to seven positively
charged residues followed by a proline (KKKHRRRP and
KKKRHWKP) (Fig. 7A). While the first segment aligned al-
most perfectly with the arginine-rich TAR RNA-binding motif
(KRKHRRRP) found in the HIV-1 Tat protein (Fig. 7A), the
second segment also showed partial resemblance to the TAR-
binding motif of Tat.
Despite the seemingly haphazard arrangement of clusters of
positively charged residues within the 7SK-binding motif in
HEXIM1, this motif nevertheless confers stringent specificity
for 7SK binding when present within the HEXIM1 backbone
(Fig. 4B). This observation could be explained by the structural
insights obtained through the characterization of the folds of
RNA-bound arginine-rich peptides and the architecture of
their peptide-binding RNA pockets in viral and phage systems
(for a review, see reference13). Studies of these model peptide-
RNA complexes reveal diverse strategies of recognition based
on structural transitions and adaptations involving both the
RNA molecules and the peptides. Induced RNA structures
include noncanonical elements, such as mismatches, base trip-
lets, and looped-out bases, which sculpture the RNA major
groove to create specific peptide-binding pockets and surfaces.
On the other hand, although the arginine-rich peptides are
related at the level of their primary amino acid sequences,
different peptides can fold as an isolated alpha-helix, beta-
hairpin, or helix-bend-helix, depending on the induced archi-
tectures of their RNA targets (13). Regarding the HEXIM1-
7SK interaction, future structural studies will reveal to what
extent adaptive transitions are involved in defining the speci-
ficity of this interaction and what specific role each segment of
the bipartite 7SK-binding motif may play in contributing to this
process.
It is important to note that when the isolated 7SK-binding
motif of HEXIM1 is fused to GFP, the specificity for 7SK is
somewhat reduced (Fig. 4B). This observation suggests that
other parts of HEXIM1 or the incorporation of P-TEFb into
the snRNP are likely to provide additional determinants to
further enhance the specificity for 7SK binding. In support of
a key role of P-TEFb in this process, it has been shown that
P-TEFb can directly and specifically bind 7SK in vitro (3). In
fact, both the conserved Thr186 in the CDK9 T-loop and a
CycT1 region between aa 255 and 333 are specifically required
for the binding (3).
The ability of P-TEFb to enhance the RNA-binding speci-
ficity of another protein is not without a precedent. In fact,
binding of the HIV-1 Tat to the TAR stem-loop structure in
vitro is notoriously not very specific. Although the binding
depends on the specific sequences in the stem and a 3-nucle-
FIG. 6. The first 18 residues of the HEXIM1 NLS are required for 7SK binding. (A) Functional redundancy for nuclear targeting among the
residues within the HEXIM1 NLS. Top: amino acid sequences of the NLS domains of wild-type and mutant HEXIM1 with the indicated alanine
substitutions within the NLS. Bottom: the wild-type and mutant HEXIM1 proteins were expressed from transfected plasmids in HeLa cells, and
their subcellular localizations were examined by anti-Flag immunofluorescence staining. Nuclei of both transfected and untransfected cells were
revealed by 4,6-diamidino-2-phenylindole staining and used as a reference. (B) The first 18 residues of HEXIM1 NLS are important for 7SK
binding in vivo. HeLa cells were transfected with plasmids expressing the indicated fHXM1 or fNLSHXM1-GFP fusion proteins containing either
wild-type or the various alanine-substituted NLS sequences described for panel A. Anti-Flag immune complexes derived from NE of transfected
cells were analyzed by Western and Northern blotting as indicated.
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otide bulge region of the TAR RNA, mutations in the apical
loop that destroy Tat-activated HIV-1 transcription do not
affect the Tat-TAR interaction in vitro (7). The inclusion of
P-TEFb into the complex, however, dramatically changes the
situation. The ability of CycT1 to interact with both Tat and
the TAR loop region enhances the specificity of the Tat-TAR
interaction and confers dependence on specific TAR loop se-
quences for Tat–TAR–P-TEFb complex formation (4, 19).
Given the observations that P-TEFb can specifically bind to
7SK in vitro (3) and that a direct interaction between HEXIM1
and CycT1 has been observed in a yeast two-hybrid assay (9),
it is likely that a similar mechanism involving multiple protein-
RNA and protein-protein interactions may be used by P-TEFb
to enhance the specificity of the HEXIM1-7SK interaction.
These observations, together with the discovery of a similar
arginine-rich RNA-binding motif in both Tat and HEXIM1,
strongly suggest that a similar architectural plan may exist to
form both the Tat–TAR–P-TEFb and the HEXIM1–7SK–P-
FIG. 7. A duplicated arginine-rich TAR-binding motif of HIV-1 Tat can substitute for the NLS of HEXIM1 for 7SK binding. (A) Sequence
alignment of the arginine-rich TAR-binding motif of Tat (HIV-1 Finland strain AAC29057) with the NLS derived from human and mouse
HEXIM1 (hHXM1 and mHXM1) and their homologues hHXM2 (AK056946), mHXM2 (BC026458), and the zebra fish (Danio rerio) zfHXM
(BG307670). Reverse type indicates amino acid identity, and shaded boxes indicate similarity. The numbers refer to the positions of the first residue
of the segments within the respective proteins. The NLS region of a HEXIM1 mutant (HXM1-NLSTat) containing the arginine-rich TAR-binding
motif of Tat near the center (underlined) is also shown. (B) Substitution of the middle one-third of the HEXIM1 NLS with the arginine-rich
TAR-binding motif of Tat restores 7SK binding. Anti-Flag immunoprecipitates were isolated from NE of HeLa cells transfected with either an
empty vector or constructs expressing the indicated Flag-tagged HEXIM1 proteins and analyzed as described in the legend for Fig. 2A. Lanes 4
and 5 contain fHXM1-NLSTat complex immunoprecipitated in the presence () or absence () of RNase A. (C) fHXM1-NLSTat binds 7SK with
slightly decreased specificity. Shown are Northern analyses of the levels of 7SK, U1, and U2 snRNAs present in HeLa NE and the various immune
complexes (Flag IP) obtained in panel B. (D) Overexpressed fHXM1-NLSTat suppresses the luciferase gene expression driven by the HIV-1 LTR.
HeLa cells were cotransfected with the HIV-1 LTR-luciferase reporter construct and the indicated HEXIM1 expression plasmids. Luciferase
activity was measured and analyzed as for Fig. 3A.
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TEFb ternary complexes. This hypothesis, while yet to be con-
firmed, raises an intriguing possibility that the formation of the
Tat–TAR–P-TEFb complex in HIV-infected cells may out-
compete and preclude the formation of the inactive HEXIM1–
7SK–P-TEFb complex, leading to the activation of HIV-1 tran-
scription.
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